Novabiotics Limited
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 2 name spellings.
3
Ending by 2030
Dec 2026
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Apr 27, 2027The maintenance fee for Peptides and their use (US 9,169,290) comes due Apr 27, 2027. Unpaid by Oct 27, 2027, it lapses early.
- 1 fee due Nov 17, 2027The maintenance fee for Inhibition of biofilm organisms (US 9,339,525) comes due Nov 17, 2027. Unpaid by May 17, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,518,093 | Topical formulation of Arginine-rich Cyclic Antimicrobial Peptides In force · High confidence | In force | High confidence | |
| US 8,324,154 | Treatment of Fungal Infections with Cyclic Antimicrobial Peptides In force · High confidence | In force | High confidence | |
| US 9,371,363 | Peptides and their use In force · From the USPTO record | In force | From the USPTO record | |
| US 9,169,290 | Peptides and their use In force · From the USPTO record | In force | From the USPTO record | |
| US 8,901,071 | Compounds and their use In force · From the USPTO record | In force | From the USPTO record | |
| US 9,364,491 | Antimicrobial compositions with cysteamine In force · From the USPTO record | In force | From the USPTO record | |
| US 9,782,423 | Antibiotic compositions comprising an antibiotic agent and cysteamine In force · From the USPTO record | In force | From the USPTO record | |
| US 11,020,414 | Antimicrobial compositions with cysteamine In force · From the USPTO record | In force | From the USPTO record | |
| US 9,339,525 | Inhibition of biofilm organisms In force · From the USPTO record | In force | From the USPTO record | |
| US 11,369,568 | Microparticles comprising a sulphur-containing compound In force · From the USPTO record | In force | From the USPTO record |
Also on record, not counted in the 12: 3 lapsed for an unpaid fee · 3 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
1 pending · 13 no status recorded